vs
Side-by-side financial comparison of bioAffinity Technologies, Inc. (BIAF) and PureCycle Technologies, Inc. (PCT). Click either name above to swap in a different company.
PureCycle Technologies, Inc. is the larger business by last-quarter revenue ($2.7M vs $1.6M, roughly 1.7× bioAffinity Technologies, Inc.). bioAffinity Technologies, Inc. runs the higher net margin — -197.0% vs -697.1%, a 500.1% gap on every dollar of revenue. bioAffinity Technologies, Inc. produced more free cash flow last quarter ($-2.6M vs $-42.0M).
bioAffinity Technologies, Inc. is a clinical-stage biotechnology firm focused on developing non-invasive in vitro diagnostic tests for early detection of cancer and respiratory diseases. It serves global healthcare markets, with a core mission to deliver accessible, high-accuracy diagnostic solutions that improve patient outcomes and reduce overall healthcare system costs.
PureCycle Technologies, Inc. is a sustainable materials firm with proprietary advanced polypropylene recycling technology. It converts contaminated polypropylene waste into high-purity virgin-equivalent resin for use in consumer goods, automotive parts, packaging and industrial products, serving global partners.
BIAF vs PCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.6M | $2.7M |
| Net Profit | $-3.1M | $-18.8M |
| Gross Margin | — | — |
| Operating Margin | -196.9% | -2196.1% |
| Net Margin | -197.0% | -697.1% |
| Revenue YoY | -27.8% | — |
| Net Profit YoY | -5.7% | 71.0% |
| EPS (diluted) | $-3.59 | $-0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.6M | $2.7M | ||
| Q3 25 | $1.4M | $2.4M | ||
| Q2 25 | $1.3M | $1.6M | ||
| Q1 25 | $1.9M | $1.6M | ||
| Q4 24 | $2.2M | $0 | ||
| Q3 24 | $2.4M | $0 | ||
| Q2 24 | $2.4M | $0 | ||
| Q1 24 | $2.4M | $0 |
| Q4 25 | $-3.1M | $-18.8M | ||
| Q3 25 | $-5.1M | $-28.4M | ||
| Q2 25 | $-4.1M | $-144.2M | ||
| Q1 25 | $-2.7M | $8.8M | ||
| Q4 24 | $-3.0M | $-64.7M | ||
| Q3 24 | $-2.0M | $-90.6M | ||
| Q2 24 | $-2.1M | $-48.2M | ||
| Q1 24 | $-2.0M | $-85.6M |
| Q4 25 | -196.9% | -2196.1% | ||
| Q3 25 | -158.6% | -1602.2% | ||
| Q2 25 | -198.2% | -2763.5% | ||
| Q1 25 | -141.7% | -2387.4% | ||
| Q4 24 | -133.5% | — | ||
| Q3 24 | -84.0% | — | ||
| Q2 24 | -87.1% | — | ||
| Q1 24 | -80.8% | — |
| Q4 25 | -197.0% | -697.1% | ||
| Q3 25 | -349.3% | -1167.5% | ||
| Q2 25 | -319.9% | -8741.8% | ||
| Q1 25 | -143.5% | 559.0% | ||
| Q4 24 | -134.4% | — | ||
| Q3 24 | -85.1% | — | ||
| Q2 24 | -88.0% | — | ||
| Q1 24 | -81.5% | — |
| Q4 25 | $-3.59 | $-0.14 | ||
| Q3 25 | $-4.74 | $-0.31 | ||
| Q2 25 | $-0.17 | $-0.81 | ||
| Q1 25 | $-0.16 | $0.05 | ||
| Q4 24 | $-17.27 | $-0.40 | ||
| Q3 24 | $-4.84 | $-0.54 | ||
| Q2 24 | $-0.19 | $-0.29 | ||
| Q1 24 | $-0.20 | $-0.52 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $6.4M | $156.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $7.3M | $45.9M |
| Total Assets | $11.0M | $922.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.4M | $156.7M | ||
| Q3 25 | $7.7M | $234.4M | ||
| Q2 25 | $802.8K | $284.1M | ||
| Q1 25 | $444.7K | $22.5M | ||
| Q4 24 | $1.1M | $15.7M | ||
| Q3 24 | $756.6K | $83.7M | ||
| Q2 24 | $801.3K | $10.9M | ||
| Q1 24 | $2.5M | $25.0M |
| Q4 25 | $7.3M | $45.9M | ||
| Q3 25 | $8.9M | $68.2M | ||
| Q2 25 | $-2.1M | $98.9M | ||
| Q1 25 | $1.4M | $238.2M | ||
| Q4 24 | $2.6M | $180.4M | ||
| Q3 24 | $3.1M | $241.4M | ||
| Q2 24 | $3.4M | $291.6M | ||
| Q1 24 | $5.3M | $336.8M |
| Q4 25 | $11.0M | $922.7M | ||
| Q3 25 | $11.5M | $989.1M | ||
| Q2 25 | $4.8M | $1.0B | ||
| Q1 25 | $5.5M | $787.3M | ||
| Q4 24 | $6.5M | $798.4M | ||
| Q3 24 | $6.6M | $788.8M | ||
| Q2 24 | $6.7M | $719.8M | ||
| Q1 24 | $8.0M | $734.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.6M | $-28.7M |
| Free Cash FlowOCF − Capex | $-2.6M | $-42.0M |
| FCF MarginFCF / Revenue | -160.7% | -1559.6% |
| Capex IntensityCapex / Revenue | 0.0% | 495.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-9.4M | $-183.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.6M | $-28.7M | ||
| Q3 25 | $-2.5M | $-38.5M | ||
| Q2 25 | $-2.6M | $-36.7M | ||
| Q1 25 | $-1.6M | $-38.9M | ||
| Q4 24 | $-1.7M | $-31.8M | ||
| Q3 24 | $-1.7M | $-33.4M | ||
| Q2 24 | $-1.5M | $-40.4M | ||
| Q1 24 | $-2.3M | $-39.2M |
| Q4 25 | $-2.6M | $-42.0M | ||
| Q3 25 | $-2.5M | $-42.4M | ||
| Q2 25 | $-2.7M | $-45.3M | ||
| Q1 25 | $-1.7M | $-53.9M | ||
| Q4 24 | $-1.7M | $-53.4M | ||
| Q3 24 | $-1.7M | $-42.6M | ||
| Q2 24 | $-1.6M | $-50.8M | ||
| Q1 24 | $-2.4M | $-53.5M |
| Q4 25 | -160.7% | -1559.6% | ||
| Q3 25 | -171.8% | -1743.1% | ||
| Q2 25 | -209.6% | -2747.1% | ||
| Q1 25 | -91.3% | -3409.6% | ||
| Q4 24 | -76.0% | — | ||
| Q3 24 | -73.1% | — | ||
| Q2 24 | -65.1% | — | ||
| Q1 24 | -99.2% | — |
| Q4 25 | 0.0% | 495.1% | ||
| Q3 25 | 0.3% | 160.3% | ||
| Q2 25 | 1.1% | 521.5% | ||
| Q1 25 | 2.7% | 949.6% | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.4% | — | ||
| Q2 24 | 1.2% | — | ||
| Q1 24 | 1.7% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -4.40× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
